Senti Biosciences, Inc.
SNTI
$1.65
$0.0553.46%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 0.00 | 338.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | 0.00 | 338.00K |
| Cost of Revenue | 35.74M | 34.86M | 34.36M | 35.71M | 36.14M |
| Gross Profit | -35.74M | -34.86M | -34.36M | -35.71M | -35.81M |
| SG&A Expenses | 21.83M | 19.26M | 19.92M | 21.15M | 25.09M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -387.00K | -184.00K | -6.00K | -6.00K | -6.00K |
| Total Operating Expenses | 57.18M | 53.94M | 54.27M | 56.85M | 61.23M |
| Operating Income | -57.18M | -53.94M | -54.27M | -56.85M | -60.89M |
| Income Before Tax | -58.32M | -54.79M | -52.79M | -70.87M | -78.62M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -58.32 | -54.79 | -52.79 | -70.87 | -78.62 |
| Earnings from Discontinued Operations | -- | -- | -- | -28.00K | 21.66M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -58.32M | -54.79M | -52.79M | -70.90M | -56.95M |
| EBIT | -57.18M | -53.94M | -54.27M | -56.85M | -60.89M |
| EBITDA | -53.45M | -50.16M | -50.43M | -52.96M | -56.60M |
| EPS Basic | -9.62 | -11.51 | -12.75 | -15.60 | -12.65 |
| Normalized Basic EPS | -2.92 | -4.12 | -4.90 | -7.36 | -7.41 |
| EPS Diluted | -9.62 | -11.51 | -12.75 | -15.60 | -12.65 |
| Normalized Diluted EPS | -2.92 | -4.12 | -4.90 | -7.36 | -7.41 |
| Average Basic Shares Outstanding | 45.33M | 23.82M | 18.38M | 18.19M | 18.06M |
| Average Diluted Shares Outstanding | 45.33M | 23.82M | 18.38M | 18.19M | 18.06M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |